SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-12-085965
Filing Date
2012-12-21
Accepted
2012-12-21 16:33:24
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 a12-29921_1s3.htm S-3 578353
2 EX-4.13 a12-29921_1ex4d13.htm EX-4.13 8575
3 EX-5.1 a12-29921_1ex5d1.htm EX-5.1 30553
4 EX-12.1 a12-29921_1ex12d1.htm EX-12.1 43845
5 EX-23.1 a12-29921_1ex23d1.htm EX-23.1 4311
6 GRAPHIC g299211ba11i001.jpg GRAPHIC 16723
7 GRAPHIC g299211ba11i002.gif GRAPHIC 5243
8 GRAPHIC g299211kai001.gif GRAPHIC 205576
9 GRAPHIC g299211kai002.gif GRAPHIC 80992
10 GRAPHIC g299211ba07i001.jpg GRAPHIC 5835
11 GRAPHIC g299211ba07i002.gif GRAPHIC 5243
  Complete submission text file 0001104659-12-085965.txt   1108051
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-185647 | Film No.: 121282299
SIC: 2835 In Vitro & In Vivo Diagnostic Substances